Macrocytic Anemia

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 3636 Experts worldwide ranked by ideXlab platform

Jie Zheng - One of the best experts on this subject based on the ideXlab platform.

  • Macrocytic Anemia is associated with the severity of liver impairment in patients with hepatitis b virus related decompensated cirrhosis a retrospective cross sectional study
    BMC Gastroenterology, 2018
    Co-Authors: Jian Yang, Bin Yan, Lihong Yang, Yajuan Fan, Feng Zhu, Jie Zheng
    Abstract:

    Macrocytic Anemia is common in liver disease. However, its role in hepatitis B virus (HBV)-related decompensated cirrhosis remains unknown. The aim of the present study was to determine the association between Macrocytic Anemia and the severity of liver impairment in patients with HBV-related decompensated cirrhosis according to the Model for End Stage Liver Disease (MELD) score. A total of 463 participants who fulfilled our criteria were enrolled in this cross-sectional study. Patients were classified into three groups according to Anemia types, diagnosed based on their mean corpuscular volume level. Multivariate linear regression analyses were used to determine the association between Macrocytic Anemia and the MELD score for patients with HBV-related decompensated cirrhosis. Patients with Macrocytic Anemia had evidently higher MELD scores (10.8 ± 6.6) than those with normocytic Anemia (8.0 ± 5.5) or microcytic Anemia (6.3 ± 5.1). The association remained robust after adjusting for age, gender, smoking, drinking, and total cholesterol (β = 1.94, CI: 0.81–3.07, P < 0.001). Macrocytic Anemia was found to be associated with the severity of liver impairment and might be a predictor for short-term mortality in patients with HBV-related decompensated cirrhosis.

  • Macrocytic Anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study.
    BMC Gastroenterology, 2018
    Co-Authors: Jian Yang, Bin Yan, Lihong Yang, Yajuan Fan, Feng Zhu, Jie Zheng
    Abstract:

    Macrocytic Anemia is common in liver disease. However, its role in hepatitis B virus (HBV)-related decompensated cirrhosis remains unknown. The aim of the present study was to determine the association between Macrocytic Anemia and the severity of liver impairment in patients with HBV-related decompensated cirrhosis according to the Model for End Stage Liver Disease (MELD) score. A total of 463 participants who fulfilled our criteria were enrolled in this cross-sectional study. Patients were classified into three groups according to Anemia types, diagnosed based on their mean corpuscular volume level. Multivariate linear regression analyses were used to determine the association between Macrocytic Anemia and the MELD score for patients with HBV-related decompensated cirrhosis. Patients with Macrocytic Anemia had evidently higher MELD scores (10.8 ± 6.6) than those with normocytic Anemia (8.0 ± 5.5) or microcytic Anemia (6.3 ± 5.1). The association remained robust after adjusting for age, gender, smoking, drinking, and total cholesterol (β = 1.94, CI: 0.81–3.07, P 

  • Macrocytic Anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study
    BMC, 2018
    Co-Authors: Jian Yang, Bin Yan, Lihong Yang, Yajuan Fan, Feng Zhu, Jie Zheng
    Abstract:

    Abstract Background Macrocytic Anemia is common in liver disease. However, its role in hepatitis B virus (HBV)-related decompensated cirrhosis remains unknown. The aim of the present study was to determine the association between Macrocytic Anemia and the severity of liver impairment in patients with HBV-related decompensated cirrhosis according to the Model for End Stage Liver Disease (MELD) score. Methods A total of 463 participants who fulfilled our criteria were enrolled in this cross-sectional study. Patients were classified into three groups according to Anemia types, diagnosed based on their mean corpuscular volume level. Multivariate linear regression analyses were used to determine the association between Macrocytic Anemia and the MELD score for patients with HBV-related decompensated cirrhosis. Results Patients with Macrocytic Anemia had evidently higher MELD scores (10.8 ± 6.6) than those with normocytic Anemia (8.0 ± 5.5) or microcytic Anemia (6.3 ± 5.1). The association remained robust after adjusting for age, gender, smoking, drinking, and total cholesterol (β = 1.94, CI: 0.81–3.07, P 

Jian Yang - One of the best experts on this subject based on the ideXlab platform.

  • Macrocytic Anemia is associated with the severity of liver impairment in patients with hepatitis b virus related decompensated cirrhosis a retrospective cross sectional study
    BMC Gastroenterology, 2018
    Co-Authors: Jian Yang, Bin Yan, Lihong Yang, Yajuan Fan, Feng Zhu, Jie Zheng
    Abstract:

    Macrocytic Anemia is common in liver disease. However, its role in hepatitis B virus (HBV)-related decompensated cirrhosis remains unknown. The aim of the present study was to determine the association between Macrocytic Anemia and the severity of liver impairment in patients with HBV-related decompensated cirrhosis according to the Model for End Stage Liver Disease (MELD) score. A total of 463 participants who fulfilled our criteria were enrolled in this cross-sectional study. Patients were classified into three groups according to Anemia types, diagnosed based on their mean corpuscular volume level. Multivariate linear regression analyses were used to determine the association between Macrocytic Anemia and the MELD score for patients with HBV-related decompensated cirrhosis. Patients with Macrocytic Anemia had evidently higher MELD scores (10.8 ± 6.6) than those with normocytic Anemia (8.0 ± 5.5) or microcytic Anemia (6.3 ± 5.1). The association remained robust after adjusting for age, gender, smoking, drinking, and total cholesterol (β = 1.94, CI: 0.81–3.07, P < 0.001). Macrocytic Anemia was found to be associated with the severity of liver impairment and might be a predictor for short-term mortality in patients with HBV-related decompensated cirrhosis.

  • Macrocytic Anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study.
    BMC Gastroenterology, 2018
    Co-Authors: Jian Yang, Bin Yan, Lihong Yang, Yajuan Fan, Feng Zhu, Jie Zheng
    Abstract:

    Macrocytic Anemia is common in liver disease. However, its role in hepatitis B virus (HBV)-related decompensated cirrhosis remains unknown. The aim of the present study was to determine the association between Macrocytic Anemia and the severity of liver impairment in patients with HBV-related decompensated cirrhosis according to the Model for End Stage Liver Disease (MELD) score. A total of 463 participants who fulfilled our criteria were enrolled in this cross-sectional study. Patients were classified into three groups according to Anemia types, diagnosed based on their mean corpuscular volume level. Multivariate linear regression analyses were used to determine the association between Macrocytic Anemia and the MELD score for patients with HBV-related decompensated cirrhosis. Patients with Macrocytic Anemia had evidently higher MELD scores (10.8 ± 6.6) than those with normocytic Anemia (8.0 ± 5.5) or microcytic Anemia (6.3 ± 5.1). The association remained robust after adjusting for age, gender, smoking, drinking, and total cholesterol (β = 1.94, CI: 0.81–3.07, P 

  • Macrocytic Anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study
    BMC, 2018
    Co-Authors: Jian Yang, Bin Yan, Lihong Yang, Yajuan Fan, Feng Zhu, Jie Zheng
    Abstract:

    Abstract Background Macrocytic Anemia is common in liver disease. However, its role in hepatitis B virus (HBV)-related decompensated cirrhosis remains unknown. The aim of the present study was to determine the association between Macrocytic Anemia and the severity of liver impairment in patients with HBV-related decompensated cirrhosis according to the Model for End Stage Liver Disease (MELD) score. Methods A total of 463 participants who fulfilled our criteria were enrolled in this cross-sectional study. Patients were classified into three groups according to Anemia types, diagnosed based on their mean corpuscular volume level. Multivariate linear regression analyses were used to determine the association between Macrocytic Anemia and the MELD score for patients with HBV-related decompensated cirrhosis. Results Patients with Macrocytic Anemia had evidently higher MELD scores (10.8 ± 6.6) than those with normocytic Anemia (8.0 ± 5.5) or microcytic Anemia (6.3 ± 5.1). The association remained robust after adjusting for age, gender, smoking, drinking, and total cholesterol (β = 1.94, CI: 0.81–3.07, P 

Yajuan Fan - One of the best experts on this subject based on the ideXlab platform.

  • Macrocytic Anemia is associated with the severity of liver impairment in patients with hepatitis b virus related decompensated cirrhosis a retrospective cross sectional study
    BMC Gastroenterology, 2018
    Co-Authors: Jian Yang, Bin Yan, Lihong Yang, Yajuan Fan, Feng Zhu, Jie Zheng
    Abstract:

    Macrocytic Anemia is common in liver disease. However, its role in hepatitis B virus (HBV)-related decompensated cirrhosis remains unknown. The aim of the present study was to determine the association between Macrocytic Anemia and the severity of liver impairment in patients with HBV-related decompensated cirrhosis according to the Model for End Stage Liver Disease (MELD) score. A total of 463 participants who fulfilled our criteria were enrolled in this cross-sectional study. Patients were classified into three groups according to Anemia types, diagnosed based on their mean corpuscular volume level. Multivariate linear regression analyses were used to determine the association between Macrocytic Anemia and the MELD score for patients with HBV-related decompensated cirrhosis. Patients with Macrocytic Anemia had evidently higher MELD scores (10.8 ± 6.6) than those with normocytic Anemia (8.0 ± 5.5) or microcytic Anemia (6.3 ± 5.1). The association remained robust after adjusting for age, gender, smoking, drinking, and total cholesterol (β = 1.94, CI: 0.81–3.07, P < 0.001). Macrocytic Anemia was found to be associated with the severity of liver impairment and might be a predictor for short-term mortality in patients with HBV-related decompensated cirrhosis.

  • Macrocytic Anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study.
    BMC Gastroenterology, 2018
    Co-Authors: Jian Yang, Bin Yan, Lihong Yang, Yajuan Fan, Feng Zhu, Jie Zheng
    Abstract:

    Macrocytic Anemia is common in liver disease. However, its role in hepatitis B virus (HBV)-related decompensated cirrhosis remains unknown. The aim of the present study was to determine the association between Macrocytic Anemia and the severity of liver impairment in patients with HBV-related decompensated cirrhosis according to the Model for End Stage Liver Disease (MELD) score. A total of 463 participants who fulfilled our criteria were enrolled in this cross-sectional study. Patients were classified into three groups according to Anemia types, diagnosed based on their mean corpuscular volume level. Multivariate linear regression analyses were used to determine the association between Macrocytic Anemia and the MELD score for patients with HBV-related decompensated cirrhosis. Patients with Macrocytic Anemia had evidently higher MELD scores (10.8 ± 6.6) than those with normocytic Anemia (8.0 ± 5.5) or microcytic Anemia (6.3 ± 5.1). The association remained robust after adjusting for age, gender, smoking, drinking, and total cholesterol (β = 1.94, CI: 0.81–3.07, P 

  • Macrocytic Anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study
    BMC, 2018
    Co-Authors: Jian Yang, Bin Yan, Lihong Yang, Yajuan Fan, Feng Zhu, Jie Zheng
    Abstract:

    Abstract Background Macrocytic Anemia is common in liver disease. However, its role in hepatitis B virus (HBV)-related decompensated cirrhosis remains unknown. The aim of the present study was to determine the association between Macrocytic Anemia and the severity of liver impairment in patients with HBV-related decompensated cirrhosis according to the Model for End Stage Liver Disease (MELD) score. Methods A total of 463 participants who fulfilled our criteria were enrolled in this cross-sectional study. Patients were classified into three groups according to Anemia types, diagnosed based on their mean corpuscular volume level. Multivariate linear regression analyses were used to determine the association between Macrocytic Anemia and the MELD score for patients with HBV-related decompensated cirrhosis. Results Patients with Macrocytic Anemia had evidently higher MELD scores (10.8 ± 6.6) than those with normocytic Anemia (8.0 ± 5.5) or microcytic Anemia (6.3 ± 5.1). The association remained robust after adjusting for age, gender, smoking, drinking, and total cholesterol (β = 1.94, CI: 0.81–3.07, P 

Lihong Yang - One of the best experts on this subject based on the ideXlab platform.

  • Macrocytic Anemia is associated with the severity of liver impairment in patients with hepatitis b virus related decompensated cirrhosis a retrospective cross sectional study
    BMC Gastroenterology, 2018
    Co-Authors: Jian Yang, Bin Yan, Lihong Yang, Yajuan Fan, Feng Zhu, Jie Zheng
    Abstract:

    Macrocytic Anemia is common in liver disease. However, its role in hepatitis B virus (HBV)-related decompensated cirrhosis remains unknown. The aim of the present study was to determine the association between Macrocytic Anemia and the severity of liver impairment in patients with HBV-related decompensated cirrhosis according to the Model for End Stage Liver Disease (MELD) score. A total of 463 participants who fulfilled our criteria were enrolled in this cross-sectional study. Patients were classified into three groups according to Anemia types, diagnosed based on their mean corpuscular volume level. Multivariate linear regression analyses were used to determine the association between Macrocytic Anemia and the MELD score for patients with HBV-related decompensated cirrhosis. Patients with Macrocytic Anemia had evidently higher MELD scores (10.8 ± 6.6) than those with normocytic Anemia (8.0 ± 5.5) or microcytic Anemia (6.3 ± 5.1). The association remained robust after adjusting for age, gender, smoking, drinking, and total cholesterol (β = 1.94, CI: 0.81–3.07, P < 0.001). Macrocytic Anemia was found to be associated with the severity of liver impairment and might be a predictor for short-term mortality in patients with HBV-related decompensated cirrhosis.

  • Macrocytic Anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study.
    BMC Gastroenterology, 2018
    Co-Authors: Jian Yang, Bin Yan, Lihong Yang, Yajuan Fan, Feng Zhu, Jie Zheng
    Abstract:

    Macrocytic Anemia is common in liver disease. However, its role in hepatitis B virus (HBV)-related decompensated cirrhosis remains unknown. The aim of the present study was to determine the association between Macrocytic Anemia and the severity of liver impairment in patients with HBV-related decompensated cirrhosis according to the Model for End Stage Liver Disease (MELD) score. A total of 463 participants who fulfilled our criteria were enrolled in this cross-sectional study. Patients were classified into three groups according to Anemia types, diagnosed based on their mean corpuscular volume level. Multivariate linear regression analyses were used to determine the association between Macrocytic Anemia and the MELD score for patients with HBV-related decompensated cirrhosis. Patients with Macrocytic Anemia had evidently higher MELD scores (10.8 ± 6.6) than those with normocytic Anemia (8.0 ± 5.5) or microcytic Anemia (6.3 ± 5.1). The association remained robust after adjusting for age, gender, smoking, drinking, and total cholesterol (β = 1.94, CI: 0.81–3.07, P 

  • Macrocytic Anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study
    BMC, 2018
    Co-Authors: Jian Yang, Bin Yan, Lihong Yang, Yajuan Fan, Feng Zhu, Jie Zheng
    Abstract:

    Abstract Background Macrocytic Anemia is common in liver disease. However, its role in hepatitis B virus (HBV)-related decompensated cirrhosis remains unknown. The aim of the present study was to determine the association between Macrocytic Anemia and the severity of liver impairment in patients with HBV-related decompensated cirrhosis according to the Model for End Stage Liver Disease (MELD) score. Methods A total of 463 participants who fulfilled our criteria were enrolled in this cross-sectional study. Patients were classified into three groups according to Anemia types, diagnosed based on their mean corpuscular volume level. Multivariate linear regression analyses were used to determine the association between Macrocytic Anemia and the MELD score for patients with HBV-related decompensated cirrhosis. Results Patients with Macrocytic Anemia had evidently higher MELD scores (10.8 ± 6.6) than those with normocytic Anemia (8.0 ± 5.5) or microcytic Anemia (6.3 ± 5.1). The association remained robust after adjusting for age, gender, smoking, drinking, and total cholesterol (β = 1.94, CI: 0.81–3.07, P 

Bin Yan - One of the best experts on this subject based on the ideXlab platform.

  • Macrocytic Anemia is associated with the severity of liver impairment in patients with hepatitis b virus related decompensated cirrhosis a retrospective cross sectional study
    BMC Gastroenterology, 2018
    Co-Authors: Jian Yang, Bin Yan, Lihong Yang, Yajuan Fan, Feng Zhu, Jie Zheng
    Abstract:

    Macrocytic Anemia is common in liver disease. However, its role in hepatitis B virus (HBV)-related decompensated cirrhosis remains unknown. The aim of the present study was to determine the association between Macrocytic Anemia and the severity of liver impairment in patients with HBV-related decompensated cirrhosis according to the Model for End Stage Liver Disease (MELD) score. A total of 463 participants who fulfilled our criteria were enrolled in this cross-sectional study. Patients were classified into three groups according to Anemia types, diagnosed based on their mean corpuscular volume level. Multivariate linear regression analyses were used to determine the association between Macrocytic Anemia and the MELD score for patients with HBV-related decompensated cirrhosis. Patients with Macrocytic Anemia had evidently higher MELD scores (10.8 ± 6.6) than those with normocytic Anemia (8.0 ± 5.5) or microcytic Anemia (6.3 ± 5.1). The association remained robust after adjusting for age, gender, smoking, drinking, and total cholesterol (β = 1.94, CI: 0.81–3.07, P < 0.001). Macrocytic Anemia was found to be associated with the severity of liver impairment and might be a predictor for short-term mortality in patients with HBV-related decompensated cirrhosis.

  • Macrocytic Anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study.
    BMC Gastroenterology, 2018
    Co-Authors: Jian Yang, Bin Yan, Lihong Yang, Yajuan Fan, Feng Zhu, Jie Zheng
    Abstract:

    Macrocytic Anemia is common in liver disease. However, its role in hepatitis B virus (HBV)-related decompensated cirrhosis remains unknown. The aim of the present study was to determine the association between Macrocytic Anemia and the severity of liver impairment in patients with HBV-related decompensated cirrhosis according to the Model for End Stage Liver Disease (MELD) score. A total of 463 participants who fulfilled our criteria were enrolled in this cross-sectional study. Patients were classified into three groups according to Anemia types, diagnosed based on their mean corpuscular volume level. Multivariate linear regression analyses were used to determine the association between Macrocytic Anemia and the MELD score for patients with HBV-related decompensated cirrhosis. Patients with Macrocytic Anemia had evidently higher MELD scores (10.8 ± 6.6) than those with normocytic Anemia (8.0 ± 5.5) or microcytic Anemia (6.3 ± 5.1). The association remained robust after adjusting for age, gender, smoking, drinking, and total cholesterol (β = 1.94, CI: 0.81–3.07, P 

  • Macrocytic Anemia is associated with the severity of liver impairment in patients with hepatitis B virus-related decompensated cirrhosis: a retrospective cross-sectional study
    BMC, 2018
    Co-Authors: Jian Yang, Bin Yan, Lihong Yang, Yajuan Fan, Feng Zhu, Jie Zheng
    Abstract:

    Abstract Background Macrocytic Anemia is common in liver disease. However, its role in hepatitis B virus (HBV)-related decompensated cirrhosis remains unknown. The aim of the present study was to determine the association between Macrocytic Anemia and the severity of liver impairment in patients with HBV-related decompensated cirrhosis according to the Model for End Stage Liver Disease (MELD) score. Methods A total of 463 participants who fulfilled our criteria were enrolled in this cross-sectional study. Patients were classified into three groups according to Anemia types, diagnosed based on their mean corpuscular volume level. Multivariate linear regression analyses were used to determine the association between Macrocytic Anemia and the MELD score for patients with HBV-related decompensated cirrhosis. Results Patients with Macrocytic Anemia had evidently higher MELD scores (10.8 ± 6.6) than those with normocytic Anemia (8.0 ± 5.5) or microcytic Anemia (6.3 ± 5.1). The association remained robust after adjusting for age, gender, smoking, drinking, and total cholesterol (β = 1.94, CI: 0.81–3.07, P 

Macrocytic Anemia - 15 days free trial to Access Experts & Abstracts